PREVIEW
OF YOUR NEWS WIDGETHealth - Hepatitis latest news
Start Of ProlarixT Phase 2 Study In Liver Cancer
Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces the initiation of a phase 2a proof-of-concept study of ProlarixT, a targeted prodrug chemotherapy being developed for the treatment of primary liver cancer (hepatocellular carcinoma or "HCC").
Medicalnewstoday.com Friday, August 29, 2008New Therapies Increasingly Being Used To Treat Liver Cancer
According to Millennium Research Group's (MRG) US Markets for Transcatheter Embolization and Occlusion Devices 2008 report, embolization particle therapies such as radioembolization spheres are increasingly being used to treat liver cancer.
Medicalnewstoday.com Friday, August 29, 2008The role of apoptosis in the pathogenesis and treatment of diseases
Dysregulation of cell death mechanisms is involved in the pathogenesis of an increasing number of diseases.
topix.net Friday, August 29, 2008
INSTALL YOUR WIDGET